Gmate SMART Blood Glucose Monitor System The Gmate SMART meter is the size of a quarter and connects to the headphone jack on an iOS device while using the Gmate SMART app to deliver blood glucose test results without the use of an adapter or Bluetooth device. With a simple …
Read More »Yearly Archives: 2014
Antibiotic Use by Age 2 Associated with Obesity Risk
Repeated exposure to broad-spectrum antibiotics in the first two years of life is associated with early childhood obesity… Repeated exposure to broad-spectrum antibiotics in the first two years of life is associated with early childhood obesity say researchers from The Children’s Hospital of Philadelphia in a retrospective study based on …
Read More »Letter from the Editor #753
Our good friend and Advisory Board member, Andrew Young, is one of the fittest type 1 patients I have ever met. He runs, cycles, surfs, does yoga, and is constantly working his body to improve his fitness especially for cardiovascular health. He believes that, as a type 1 patient, it …
Read More »Editor’s Note, DCMS #212
Patients often have to deal with problems we never think of and that makes it hard for them to manage their diabetes. This becomes most important when our patients are insulin users, especially if they have tactile problems or arthritis or joint problems. We try to make things easier by …
Read More »Diabetes Mellitus 101 for Cardiologists, Part 3
In this week’s Homerun Slides, courtesy Dr. Stanley Schwartz, we delve deeper into the possible explanations for the increase in mortality with tight glycemic control in the ACCORD trial as well as the effects of hypoglycemia on the cardiovascular system…. To download the complete set of these slides in PowerPoint (.ppt) …
Read More »Handbook of Diabetes, 4th Ed., Excerpt #15: Diabetic Nephropathy
Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Diabetic nephropathy is a clinical diagnosis based upon the detection of proteinuria in a patient with diabetes in the absence of another obvious cause such as infection. Many of these patients will also be hypertensive, have retinopathy and, in advanced stages, renal …
Read More »Letter from the Editor, #752
The diabetes drug arena is getting more crowded by the day as new classes of drugs like SGLT-2 inhibitors and GLP-1 analogs seem to be getting approved at a quick pace. In addition there are classes of drugs that are in phase 2 and 3 trials that we have yet …
Read More »Garmin Vivofit
Garmin Vivofit The Heart Rate Watch Company rated this the best of show for CES 2014. Unlike bands that have to be recharged every few days, it uses a coin battery that should last a year. It tracks inactivity with a red bar that grows as you sit to remind …
Read More »Editor’s Note, GLP-1 Agonist Special Edition, October 2014
I was in a doctor’s office last week and reached into a drawer to get a pen and, lo and behold, I came out with one of those old metal GLP-1 promotional pens. It was silver with orange yellow and blue-green strips, and felt really good in my hand. It …
Read More »Stricter Glycemic Control after Coronary Artery Bypass Surgery Evaluated
Prospective study shows that maintenance of glucose levels in a liberal target range is safer and more beneficial than a tight target range after CABG… Hyperglycemia after coronary artery bypass graft (CABG) has been associated with increased mortality but according to recent studies, regulating glucose levels in a liberal target …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.